Drugs / Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00161850 | Feb → Aug 2002 | tick-borne encephalitis | Pfizer | Completed | No outcome recorded |
| Phase 2 | NCT00161889 | Feb → Aug 2002 | tick-borne encephalitis | Pfizer | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00161876 | May → Aug 2002 | tick-borne encephalitis | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00161889 ↗ |
| Modality | Vaccine | “TBE vaccine” NCT00161850 ↗ |